Sector ratings Lonza Group AG

Equities

Real-time Estimate Cboe Europe Other stock markets 02:32:42 21/01/2026 pm IST			5-day change	1st Jan Change
551.10 ^CHF	+1.38%		-1.65%	+2.05%

14/01	Lonza Group AG Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 10:30 AM
18/12	Swiss trade surplus at CHF 3.841 bln in November	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LONZA GROUP AG	4.83TCr		AAA
SEAGEN INC.	4.32TCr	-	-	-	-	-	-	-
IQVIA HOLDINGS INC.	3.98TCr		AAA
BEONE MEDICINES AG	3.7TCr		-
CELLTRION, INC.	3.07TCr		A
REVOLUTION MEDICINES, INC.	2.25TCr	-	B	-		-
IMMUNOMEDICS, INC.	2.03TCr	-	-	-	-	-	-	-
MEDPACE HOLDINGS, INC.	1.7TCr		BBB
PPD, INC.	1.66TCr	-	-	-	-	-	-	-
EUROFINS SCIENTIFIC SE	1.46TCr		AA
ICON PUBLIC LIMITED COMPANY	1.35TCr		AA
REGENCELL BIOSCIENCE HOLDINGS LIMITED	1.2TCr	-	-	-	-	-	-	-
ASCENDIS PHARMA A/S	1.32TCr	-	-	-		-
TEMPUS AI, INC.	1.19TCr	-	A	-		-
IONIS PHARMACEUTICALS, INC.	1.26TCr	-	A	-		-
PRA HEALTH SCIENCES, INC.	1.1TCr	-	-	-	-	-	-	-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	1.07TCr		A
BIO-TECHNE CORPORATION	1.08TCr		A
QIAGEN N.V.	1.14TCr		AAA
PROMETHEUS BIOSCIENCES, INC.	955.86Cr	-	-	-	-	-	-	-
Average	2.03TCr		AA
Weighted average by Cap.			AA